What is Cytokinetics's net investment in lease?

Cytokinetics (CYTK) reported net investment in lease of $74.55M in Q1 2026.

How has Cytokinetics's net investment in lease changed year-over-year?

Cytokinetics's net investment in lease decreased by 3.7% year-over-year, from $77.44M to $74.55M.

What is the long-term trend for Cytokinetics's net investment in lease?

Over 5 years (2020 to 2025), Cytokinetics's net investment in lease has grown at a 91.8% compound annual growth rate (CAGR), from $2.92M to $75.98M.

Cytokinetics CYTK Net Investment in Lease

Net Investment in Lease at other companies

Boston ScientificBSX

——

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's net investment in lease?: Cytokinetics (CYTK) reported net investment in lease of $74.55M in Q1 2026.
How has Cytokinetics's net investment in lease changed year-over-year?: Cytokinetics's net investment in lease decreased by 3.7% year-over-year, from $77.44M to $74.55M.
What is the long-term trend for Cytokinetics's net investment in lease?: Over 5 years (2020 to 2025), Cytokinetics's net investment in lease has grown at a 91.8% compound annual growth rate (CAGR), from $2.92M to $75.98M.